TrialSignal
Clinical trial intelligence report
Opioid Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT04452344-Jul 28, 2026
NCT ID
NCT04452344
Status
ACTIVE_NOT_RECRUITING
Phase
PHASE3
Sponsor
Rutgers, The State University of New Jersey
Executive brief
Investment-Ready Snapshot
Opioid Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain is a PHASE3 clinical asset sponsored by Rutgers, The State University of New Jersey in Opioid Use. SEO and diligence focus: opioid-containing analgesic, two over-the-counter analgesics, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04452344
Indication
Opioid Use
Modality
combination therapy
Target
opioid-containing analgesic, two over-the-counter analgesics
Intervention
opioid-containing analgesic, two over-the-counter analgesics
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.